SBI Securities’s Whitehawk Therapeutics WHWK Stock Holding History

SBI Securities’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.45K	Buy	317 +294	+1,278%	+$1.22K	﹤0.01%	2670
2026 Q1	$79	Buy	23 +4	+21%	+$13	﹤0.01%	3471
2025 Q4	$46	Hold	19	–	–	﹤0.01%	3590
2025 Q3	$36	Hold	19	–	–	﹤0.01%	3800
2025 Q2	$36	Sell	19 -1	-5%	-$2	﹤0.01%	3795
2025 Q1	$36	Sell	20 -408	-95%	-$1.06K	﹤0.01%	3736
2024 Q4	$1.35K	Buy	+428	New	+$970	﹤0.01%	2477

Other funds holding WHWK

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECM

Evergreen Capital Management Bellevue, Washington $5.7B AUM 32.06% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

SBI Securities's WHWK Position: Q2 2026 in Review

SBI Securities increased its Whitehawk Therapeutics (WHWK) stake by 1,278% in Q2 2026, buying an estimated $1.22K and bringing the position to 317 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2670.

SBI Securities first reported a position in WHWK in Q4 2024 and has held it in 7 quarters since. 8 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

SBI Securities held 317 shares of Whitehawk Therapeutics worth $1.45K as of Q2 2026.
SBI Securities bought 294 Whitehawk Therapeutics shares in Q2 2026, an estimated $1.22K.
Whitehawk Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2670 holding.
SBI Securities first reported a position in Whitehawk Therapeutics in Q4 2024 and has held it in 7 quarters since.
8 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.